| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Mettens P, Dubois PM, Demoitié MA, Bayat B, Donner MN, Bourguignon P, Stewart VA, Heppner DG, Garçon N, Cohen J. Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Vaccine. 26: 1072-82. PMID 18258343 DOI: 10.1016/j.vaccine.2007.12.018 |
0.223 |
|
| 2011 |
Collin N, Dubois PM. The Vaccine Formulation Laboratory: a platform for access to adjuvants. Vaccine. 29: A37-9. PMID 21684427 DOI: 10.1016/j.vaccine.2011.04.125 |
0.217 |
|
| 2005 |
Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, et al. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine. 23: 2243-50. PMID 15755604 DOI: 10.1016/J.Vaccine.2005.01.142 |
0.212 |
|
| 2011 |
Agnandji ST, Fendel R, Mestré M, Janssens M, Vekemans J, Held J, Gnansounou F, Haertle S, von Glasenapp I, Oyakhirome S, Mewono L, Moris P, Lievens M, Demoitie MA, Dubois PM, et al. Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D). Plos One. 6: e18559. PMID 21494604 DOI: 10.1371/journal.pone.0018559 |
0.211 |
|
| 2023 |
Xu S, Duan H, An Y, Jin X, Duan M, Dubois PM, Huang Y, Xu K, Du H, Kleanthous H, Dai L, Gao GF. Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™. Vaccine. PMID 36967286 DOI: 10.1016/j.vaccine.2023.03.035 |
0.204 |
|
| 2011 |
Ansong D, Asante KP, Vekemans J, Owusu SK, Owusu R, Brobby NA, Dosoo D, Osei-Akoto A, Osei-Kwakye K, Asafo-Adjei E, Boahen KO, Sylverken J, Adjei G, Sambian D, Apanga S, ... ... Dubois P, et al. T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children. Plos One. 6: e18891. PMID 21556142 DOI: 10.1371/Journal.Pone.0018891 |
0.203 |
|
| 2023 |
Khan MS, Jakob V, Singh R, Rajmani RS, Kumar S, Lemoine C, Kleanthous H, Ringe RP, Dubois PM, Varadarajan R. Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics. 15. PMID 38140101 DOI: 10.3390/pharmaceutics15122759 |
0.2 |
|
| 2021 |
Dalvie NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, Biedermann AM, Crowell LE, Kaur K, Kumru OS, Carter L, Yu J, Chang A, McMahan K, Courant T, Lebas C, Lemnios AA, ... ... Dubois PM, et al. Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34493582 DOI: 10.1073/pnas.2106845118 |
0.199 |
|
| 2022 |
O'Donnell JS, Isaacs A, Jakob V, Lebas C, Barnes JB, Reading PC, Young PR, Watterson D, Dubois PM, Collin N, Chappell KJ. Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine. Frontiers in Immunology. 13: 976968. PMID 36119058 DOI: 10.3389/fimmu.2022.976968 |
0.199 |
|
| 2021 |
Dalvie NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, Biedermann AM, Crowell LE, Kaur K, Kumru O, Carter L, Yu J, Chang A, McMahan K, Courant T, Lebas C, Lemnios AA, ... ... Dubois PM, et al. Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters. Biorxiv : the Preprint Server For Biology. PMID 33688647 DOI: 10.1101/2021.03.03.433558 |
0.197 |
|
| 2007 |
Stewart VA, McGrath SM, Dubois PM, Pau MG, Mettens P, Shott J, Cobb M, Burge JR, Larson D, Ware LA, Demoitie MA, Weverling GJ, Bayat B, Custers JH, Dubois MC, et al. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Infection and Immunity. 75: 2283-90. PMID 17307942 DOI: 10.1128/Iai.01879-06 |
0.19 |
|
| 2023 |
Reinke S, Pantazi E, Chappell GR, Sanchez-Martinez A, Guyon R, Fergusson JR, Salman AM, Aktar A, Mukhopadhyay E, Ventura RA, Auderset F, Dubois PM, Collin N, Hill AVS, Bezbradica JS, et al. Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms. Cell Reports. Medicine. 101245. PMID 37913775 DOI: 10.1016/j.xcrm.2023.101245 |
0.19 |
|
| 2010 |
Nieuwenhuis I, Beenhakker N, Bogers WM, Otting N, Bontrop RE, Dubois P, Mooij P, Heeney JL, Koopman G. No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication. The Journal of General Virology. 91: 2974-84. PMID 20826621 DOI: 10.1099/vir.0.022772-0 |
0.189 |
|
| 2018 |
Younis SY, Barnier-Quer C, Heuking S, Sommandas V, Brunner L, Vd Werff N, Dubois P, Friede M, Kocken C, Collin N, Remarque E. Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation. Bmc Immunology. 19: 6. PMID 29386070 DOI: 10.1186/s12865-018-0245-0 |
0.187 |
|
| 2010 |
Roulet N, Dubois P, Aoussat A, Le Coq M. The inegration of new technologies: The stakes of knowledge International Journal of Product Development. 12: 126-140. DOI: 10.1504/Ijpd.2010.034992 |
0.172 |
|
| 2011 |
Cavanagh DR, Dubois PM, Holtel A, Kisser A, Leroy O, Locke E, Moorthy VS, Remarque EJ, Shi YP. Towards validated assays for key immunological outcomes in malaria vaccine development. Vaccine. 29: 3093-5. PMID 21296116 DOI: 10.1016/j.vaccine.2011.01.070 |
0.167 |
|
| 2019 |
Marcandalli J, Fiala B, Ols S, Perotti M, de van der Schueren W, Snijder J, Hodge E, Benhaim M, Ravichandran R, Carter L, Sheffler W, Brunner L, Lawrenz M, Dubois P, Lanzavecchia A, et al. Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus. Cell. 176: 1420-1431.e17. PMID 30849373 DOI: 10.1016/J.Cell.2019.01.046 |
0.166 |
|
| 2008 |
Scaravetti D, Dubois P, Duchamp R. Qualification of rapid prototyping tools: proposition of a procedure and a test part The International Journal of Advanced Manufacturing Technology. 38: 683-690. DOI: 10.1007/S00170-007-1129-2 |
0.165 |
|
| 2015 |
Ranaivomanana P, Raharimanga V, Dubois PM, Richard V, Rasolofo Razanamparany V. Study of the BCG Vaccine-Induced Cellular Immune Response in Schoolchildren in Antananarivo, Madagascar. Plos One. 10: e0127590. PMID 26214514 DOI: 10.1371/journal.pone.0127590 |
0.159 |
|
| 2023 |
Mittal N, Kumar S, Rajmani RS, Singh R, Lemoine C, Jakob V, Bj S, Jagannath N, Bhat M, Chakraborty D, Pandey S, Jory A, Sa SS, Kleanthous H, Dubois P, et al. Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants. Npj Vaccines. 8: 161. PMID 37880298 DOI: 10.1038/s41541-023-00755-2 |
0.156 |
|
| 2002 |
Ismaili J, Rennesson J, Aksoy E, Vekemans J, Vincart B, Amraoui Z, Van Laethem F, Goldman M, Dubois PM. Monophosphoryl lipid A activates both human dendritic cells and T cells. Journal of Immunology (Baltimore, Md. : 1950). 168: 926-32. PMID 11777991 |
0.15 |
|
| 1991 |
Roussilhon C, Hundt E, Agrapart M, Stüber W, Knapp B, Dubois P, Ballet JJ. Responses of T cells from sensitized donors to recombinant and synthetic peptides corresponding to sequences of the Plasmodium falciparum SERP antigen. Immunology Letters. 25: 149-53. PMID 1704344 DOI: 10.1016/0165-2478(90)90107-2 |
0.148 |
|
| 2001 |
Walzer T, Joubert G, Dubois PM, Tomkowiak M, Arpin C, Pihlgren M, Marvel J. Characterization at the single-cell level of naive and primed CD8 T cell cytokine responses. Cellular Immunology. 206: 16-25. PMID 11161434 DOI: 10.1006/CIMM.2000.1720 |
0.141 |
|
| 1997 |
Pihlgren M, Dubois PM, Tomkowiak M, Sjögren T, Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. The Journal of Experimental Medicine. 184: 2141-51. PMID 8976170 DOI: 10.1084/JEM.184.6.2141 |
0.128 |
|
| 1999 |
Pihlgren M, Arpin C, Walzer T, Tomkowiak M, Thomas A, Marvel J, Dubois PM. Memory CD44(int) CD8 T cells show increased proliferative responses and IFN-gamma production following antigenic challenge in vitro. International Immunology. 11: 699-706. PMID 10330275 DOI: 10.1093/INTIMM/11.5.699 |
0.127 |
|
| 2003 |
Beloeil L, Tomkowiak M, Angelov G, Walzer T, Dubois P, Marvel J. In vivo impact of CpG1826 oligodeoxynucleotide on CD8 T cell primary responses and survival. Journal of Immunology (Baltimore, Md. : 1950). 171: 2995-3002. PMID 12960324 |
0.127 |
|
| 2008 |
Shott JP, McGrath SM, Pau MG, Custers JH, Ophorst O, Demoitié MA, Dubois MC, Komisar J, Cobb M, Kester KE, Dubois P, Cohen J, Goudsmit J, Heppner DG, Stewart VA. Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice. Vaccine. 26: 2818-23. PMID 18455276 DOI: 10.1016/J.Vaccine.2008.03.080 |
0.122 |
|
| 1994 |
Dubois PM, Andris F, Shapiro RA, Gilliland LK, Kaufman M, Urbain J, Ledbetter JA, Leo O. T cell long-term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction European Journal of Immunology. 24: 348-354. PMID 7905417 DOI: 10.1002/EJI.1830240212 |
0.116 |
|
| 1992 |
Dubois PM, Stepinski J, Urbain J, Sibley CH. Role of the transmembrane and cytoplasmic domains of surface IgM in endocytosis and signal transduction European Journal of Immunology. 22: 851-857. PMID 1547827 DOI: 10.1002/Eji.1830220333 |
0.097 |
|
| 1997 |
Pihlgren M, Dubois P, Tomkowiak M, Sjögren T, Marvel J. Generation of resting, hyper-reactive memory CD8+ T cells Immunology Letters. 56: 198-199. DOI: 10.1016/S0165-2478(97)85794-X |
0.084 |
|
| 1991 |
Rooney JW, Dubois PM, Sibley CH. Cross-linking of surface IgM activates NF-χB in B lymphocyte European Journal of Immunology. 21: 2993-2998. PMID 1748149 DOI: 10.1002/Eji.1830211214 |
0.083 |
|
| 2010 |
Dubois PG, Olsefski GT, Flint-Garcia S, Setter TL, Hoekenga OA, Brutnell TP. Physiological and genetic characterization of end-of-day far-red light response in maize seedlings. Plant Physiology. 154: 173-86. PMID 20668057 DOI: 10.1104/Pp.110.159830 |
0.078 |
|
| 2010 |
Parida SK, Magalhaes I, Dubois P, Janetzki S. Training in immunology of relevance to global health issues in resource poor settings. European Journal of Immunology. 40: 1228-31. PMID 20432488 DOI: 10.1002/eji.201090022 |
0.038 |
|
| 2011 |
Dubois PG, Brutnell TP. Topology of a maize field: distinguishing the influence of end-of-day far-red light and shade avoidance syndrome on plant height. Plant Signaling & Behavior. 6: 467-70. PMID 21364314 DOI: 10.4161/psb.6.4.14305 |
0.037 |
|
| Hide low-probability matches. |